Your browser doesn't support javascript.
loading
Corrigendum to "Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings" [Bioorg. Med. Chem. Lett. 28(13) (2018) 2320-2323].
Willemse, Tom; Eiselt, Emilie; Hollanders, Karlijn; Schepens, Wim; van Vlijmen, Herman W T; Chung, Nga N; Blais, Véronique; Holleran, Brian; Longpré, Jean-Michel; Schiller, Peter W; Maes, Bert U W; Sarret, Philippe; Gendron, Louis; Ballet, Steven.
Afiliação
  • Willemse T; Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; Organic Synthesis Division, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
  • Eiselt E; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du CHUS, Université de Sherbrooke, 3001 12(e)Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada.
  • Hollanders K; Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium; Organic Synthesis Division, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
  • Schepens W; Discovery Sciences, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • van Vlijmen HWT; Discovery Sciences, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
  • Chung NN; Laboratory of Chemical Biology and Peptide Research, Montreal Clinical Research Institute, 110 avenue des Pins Ouest, Montreal, Quebec H2W 1R7, Canada.
  • Blais V; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du CHUS, Université de Sherbrooke, 3001 12(e)Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada.
  • Holleran B; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du CHUS, Université de Sherbrooke, 3001 12(e)Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada.
  • Longpré JM; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du CHUS, Université de Sherbrooke, 3001 12(e)Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada.
  • Schiller PW; Laboratory of Chemical Biology and Peptide Research, Montreal Clinical Research Institute, 110 avenue des Pins Ouest, Montreal, Quebec H2W 1R7, Canada.
  • Maes BUW; Organic Synthesis Division, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
  • Sarret P; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du CHUS, Université de Sherbrooke, 3001 12(e)Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada. Electronic address: philippe.sarret@USherbrooke.ca.
  • Gendron L; Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Centre de Recherche du CHUS, Université de Sherbrooke, 3001 12(e)Avenue Nord, Sherbrooke, Quebec J1H 5N4, Canada. Electronic address: louis.gendron@USherbrooke.ca.
  • Ballet S; Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium. Electronic address: sballet@vub.ac.be.
Bioorg Med Chem Lett ; 28(20): 3418, 2018 11 01.
Article em En | MEDLINE | ID: mdl-30195888

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article